Vivos Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD for 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Vivos Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate for 2022.
  • Vivos Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $100K, a 50% decline year-over-year.
Share-based Payment Arrangement, Expense, Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $700K Jan 1, 2022 Dec 31, 2022 10-K 2023-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.